Liposomes as MR contrast agents: Pros and cons
- 1 December 1991
- journal article
- smrm workshop
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 22 (2) , 304-308
- https://doi.org/10.1002/mrm.1910220229
Abstract
Liposomes are generally thought of as being useful for entrapping drugs within their internal aqueous space. When used with MR contrast agents, this has the drawback that water flux across the membrance bilayer is limiting to contrast enhancement. This can be partially overcome by making the liposomes very small, such that surface area is relatively great compared to internal volume, thereby facilitating water exchange. Alternatively the membranes can be designed to be permeable to water but this may render the vesicles unstable in serum. Another approach is to incorporate the contrast agents into the lipid bilayer. By designing novel complexes of manganese with the ligands incorporated onto dual acyl chains, we have achieved R1 and R2 values of over 20/mmol sec−1 or more than five times higher than Gd-DTPA. Hepatic metastasis detection is significantly improved in rats at doses of only 10 μmol/kg manganese. Membrane-bound manganese complexes function as highly effective liver imaging agents and merit further study for development as agents to undergo human clinical trials. © 1991 Academic Press, Inc.Keywords
This publication has 16 references indexed in Scilit:
- A Pharmacokinetic and MRI Study of Unilamellar Gadolinium-, Manganese-, and Iron-DTPA-Stearate Liposomes as Organ-Specific Contrast AgentsInvestigative Radiology, 1990
- Biodistribution and Clearance of Liposomal Gadolinium-DTPAInvestigative Radiology, 1990
- The effect of lipid composition on the relaxivity of Gd-DTPA entrapped in lipid vesicles of defined sizeBiochimica et Biophysica Acta (BBA) - Biomembranes, 1990
- Rapid assessment of liposomal stability in blood by an aqueous nitroxide spin labelJournal of Biochemical and Biophysical Methods, 1989
- Liposomal Gd-DTPA: preparation and characterization of relaxivity.Radiology, 1989
- Gadolinium-DTPA Liposomes as a Potential MRI Contrast AgentInvestigative Radiology, 1988
- Gadolinium‐labeled liposomes containing paramagnetic amphipathic agents: Targeted MRI contrast agents for the liverMagnetic Resonance in Medicine, 1988
- Gadolinium-labeled liposomes: targeted MR contrast agents for the liver and spleen.Radiology, 1987
- Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: biodistribution and imaging studies.Radiology, 1987
- Gadolinium-DTPA in the assessment of liver tumours by magnetic resonance imagingClinical Radiology, 1986